- Home
- PCYO vs ABEO Comparison
PCYO vs ABEO Comparison
Compare PCYO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCYO | ABEO |
|---|---|---|
| Founded | 1976 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.5M | 399.5M |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PCYO | ABEO |
|---|---|---|
| Price | $11.06 | $5.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 76.1K | ★ 1.1M |
| Earning Date | 04-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.50 | ★ 165.16 |
| EPS | ★ 0.36 | N/A |
| Revenue | $1,227,787.00 | ★ $2,998,000.00 |
| Revenue This Year | N/A | $1,024.31 |
| Revenue Next Year | N/A | $145.42 |
| P/E Ratio | $30.86 | ★ N/A |
| Revenue Growth | 171.54 | ★ 258.18 |
| 52 Week Low | $9.71 | $4.00 |
| 52 Week High | $12.44 | $7.65 |
Technical Indicators
Market Signals| Indicator | PCYO | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 33.09 |
| Support Level | $10.46 | $5.23 |
| Resistance Level | $11.52 | $5.55 |
| Average True Range (ATR) | 0.20 | 0.21 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 6.76 | 11.88 |
Price Performance
Historical ComparisonAbout PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.